Autohemotherapy is a technique used all over the world to boost the immune system.
Autohemotherapy is very simple. A small amount of blood is withdrawn from a vein and re-introduced into a muscle by injection. This creates a tiny inflammatory response that acts very much like a wound. The muscle is slightly injured by the injection since the needle used (no matter how small the gauge) is larger than the capillaries. Injured capillaries leak cell platelets into the tissues, thus triggering the release of inflammatory proteins. The immune system is now activated. If there are foreign proteins in the blood, these proteins are picked up by antigen-presenting cells and given to the T cells of the immune system to make the appropriate antibodies.
Major autohemotherapy or MAH
MAH is similar to an IV vitamin drip. The difference is that your blood is first drawn from your vein into an IV bag, then medical ozone is infused into the bag. After your blood and ozone are mixed together in the bag, the mixture will be dripped back into your vein. As a result, no ozone actually enters your bloodstream. Instead, the biological byproducts of the external mixing of your blood with ozone (ozinides, etc.) are actually creating a healing effect.
Who cannot receive MAH?
- Those with a Glucose-6-phosphate dehydrogenase deficiency (favism, acute hemolytic anemia). This is a rare condition pre-screened prior to treatment.
- Hyperthyroidism if not controlled
- Women during the first 3 months of pregnancy
- MAH is not recommended in leukemia